Author

Hui Lu

Observed name: H Lu

Institution: Fifth Tianjin Central Hospital

Observed institutions: Sun Yat-sen University, Shanghai Jiao Tong University, Fifth Tianjin Central Hospital, Sun Yat-sen University Cancer Center, Central Hospital of Zibo, State Key Laboratory of Oncology in South China, Zhejiang University of Technology

ORCID: 0000-0003-1760-6749

Observed ORCID: 0000-0003-1760-6749

OpenAlex ID: A5103267315

A clinical study of all-trans-retinoid-induced differentiation therapy of advanced thyroid cancer

2007 · Yifan Zhang, Shiquan Jia, et al. · Nuclear Medicine Communications · 44

Prognostic significance of a combined and controlled nutritional status score and EBV-DNA in patients with advanced nasopharyngeal carcinoma: a long-term follow-up study

2021 · Hui Lu, Shanshan Guo, et al. · Cancer Biology and Medicine · 9

Downregulated Long Noncoding RNA DGCR5 Acts as a New Promising Biomarker for the Diagnosis and Prognosis of Ovarian Cancer

2019 · Hongxiao Chen, Xiufang Tian, et al. · Technology in Cancer Research & Treatment · 9

Highly expressed circ_0000285 from serum and cervical exfoliated cells as a novel biomarker for the diagnosis of early stage-cervical cancer

2023 · Hongxiao Chen, Xiufang Tian, et al. · Journal of Obstetrics and Gynaecology · 8

Elevated serum growth differentiation factor 15 in multiple system atrophy patients: A case control study

2020 · Tao Yue, Hui Lu, et al. · World Journal of Clinical Cases · 6

[Efficacy and safety of triptorelin acetate microspheres for injection versus triptorelin acetate for injection in Chinese patients with endometriosis: a multicenter, randomized, double-blind, phase Ⅲ non-inferiority clinical trial].

2026 · A M Zhao, Y Wang, et al. · PubMed

Sino-C, a novel sinomenine derivative, induces cell death by disrupting cholesterol homeostasis in colorectal cancer cells

2025 · Yan-ming Zhang, Hui Lu, et al. · Acta Pharmacologica Sinica

Works count: 7

Citation count: 76

H-index: 5

I10-index: 1